Geneva Capital Management LLC Trims Position in Option Care Health, Inc. (NASDAQ:OPCH)

Geneva Capital Management LLC lessened its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 5.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 743,520 shares of the company’s stock after selling 44,958 shares during the period. Geneva Capital Management LLC owned 0.44% of Option Care Health worth $17,250,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of OPCH. UMB Bank n.a. raised its holdings in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after acquiring an additional 346 shares during the period. International Assets Investment Management LLC raised its holdings in shares of Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after acquiring an additional 2,757 shares during the period. Quarry LP raised its holdings in shares of Option Care Health by 327.7% during the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after acquiring an additional 2,628 shares during the period. Blue Trust Inc. raised its holdings in shares of Option Care Health by 16.9% during the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock worth $109,000 after acquiring an additional 681 shares during the period. Finally, Venturi Wealth Management LLC raised its holdings in shares of Option Care Health by 2,621.3% during the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock worth $110,000 after acquiring an additional 4,561 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. JMP Securities reiterated a “market outperform” rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. JPMorgan Chase & Co. raised their price objective on Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Barrington Research raised their price objective on Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research report on Thursday, February 27th. Finally, Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and raised their price objective for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $32.88.

Option Care Health Stock Performance

NASDAQ OPCH opened at $34.60 on Thursday. The company has a market cap of $5.72 billion, a P/E ratio of 29.08, a P/E/G ratio of 2.30 and a beta of 1.33. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The stock has a 50-day moving average of $29.38 and a two-hundred day moving average of $28.14. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.85.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares of the company’s stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.